05.28.2015

This week’s headlines (week of May 25, 2015)

Share on FacebookTweet about this on TwitterPin on PinterestShare on Google+Email this to someone

newsgraphic

Four new fibro drugs may be on the way. (Let’s hope these actually work without all the nasty side effects!)

Tonix Pharmaceuticals Holding Corp. will give a sneak peek at one of those potential drugs next month during the 16th Annual European Congress of Rheumatology in Rome, Italy. TNX-102 SL, also known as cyclobenzaprine HCl sublingual tablet 2.8 mg, is intended to reduce fibro symptoms by improving sleep. Tonix is conducting a Phase 3 trial of TNX-102 SL, involving about 500 fibro patients in 35 clinical centers around the U.S.

New UK research may lead to a blood test to diagnose fibro.

New Queensland research hints at what might be causing ME/CFS.

An Israeli researcher is studying if cannabis is an effective treatment for fibro. Apparently, award-winning actor and fellow fibro sufferer Morgan Freeman already knows the answer to that question! In this story, he advocates for the use of medical marijuana and says he regularly partakes of weed to relieve his fibro pain.

Health Rising wants to know if you’ve ever taken a lab test that’s actually led to better treatment of fibro and/or ME/CFS. Take the survey here.

This press release from the American Pain Society has been circulating like crazy on facebook for the past two weeks. I thought it was already widely accepted that fibro is a lifelong “central nervous system disorder, which is responsible for amplified pain that shoots through the body in those who suffer from it,” but maybe someone else can tell me why this is suddenly hot news? (Please comment below.)

Attention Alabama residents: The University of Alabama Birmingham’s Neuroinflammation, Pain & Fatigue Lab is looking for fibro patients who are willing to participate in an upcoming onsite trial. The trial will require multiple blood draws and will attempt to identify certain biomarkers that are unique to those with fibro. The lab is headed by Dr. Jarred Younger, who was previously with Stanford University. Younger has been conducting some of the most promising fibro/ME research in the country and is probably best known for his research into the use of low-dose naltrexone to treat fibro. Another trial discovered an increase in levels of leptin in the blood in ME/CFS patients. (If you have ME/CFS and feel like nothing is ever going to help relieve your symptoms, watch watch this video! Younger’s leptin research might just restore your hope!) If you’re interested in participating in UAB’s ongoing research, please complete this survey.

And yes, I know you’re sick of hearing researchers tell you to go take a walk or join a gym, but here’s yet yet another study that shows exercise reduces fibromyalgia pain.

That’s it for this week, folks. Did I miss anything big? If so, comment below, so I can add it to next week’s news roundup!

Share on FacebookTweet about this on TwitterPin on PinterestShare on Google+Email this to someone

Speak Your Mind

*


Wordpress content guard plugin by JaspreetChahal.org